Avisa Diagnostics Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a AVBT.CN research report →
Companywww.avisadx.com
Avisa Diagnostics Inc. operates a clinical-stage medical device company. It is developing the Avisa BreathTest, a novel drug/device biomarker technology platform that enables the ultra-rapid detection of virulent bacterial pathogens, detecting and monitoring bacterial load after the patient inhales or ingests its proprietary drug substrates.
- CEO
- David S. Joseph
- IPO
- 2010
- HQ
- Santa Fe, NM, US
Price Chart
Valuation
- Market Cap
- $123.66K
- P/E
- -0.23
- P/S
- 0.32
- P/B
- -0.32
- EV/EBITDA
- -0.20
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 46.53%
- Op Margin
- -251.59%
- Net Margin
- -263.83%
- ROE
- 408.59%
- ROIC
- 187.73%
Growth & Income
- Revenue
- $277.83K · -66.88%
- Net Income
- $-733,000 · 86.95%
- EPS
- $-0.14 · 87.72%
- Op Income
- $-699,000
- FCF YoY
- 67.09%
Performance & Tape
- 52W High
- $0.04
- 52W Low
- $0.04
- 50D MA
- $0.04
- 200D MA
- $0.04
- Beta
- 0.00
- Avg Volume
- 0
Get TickerSpark's AI analysis on AVBT.CN
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our AVBT.CN Coverage
We haven't published any research on AVBT.CN yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate AVBT.CN Report →